Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/17/1999CN1211178A Method of inhibiting photoaging of skin
03/17/1999CN1211166A Liquid oral compositions comprising a calcium compound and an acidulant
03/17/1999CN1210864A New medicine for curing presenile dementia and cerebral apoplexy sequelae
03/17/1999CN1210859A New benzimidazole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them
03/17/1999CN1210721A Medicine for burn and its preparing process
03/17/1999CN1210716A Method for producing animal pesticide
03/17/1999CN1210715A Medicine for curing malignant tumour
03/17/1999CN1042540C Process for preparation of 4-amino 'delta' 4-3-ketosteroids via 4-nitro-'delta' 4-3-ketostoroids
03/17/1999CN1042539C 11,21-bisphenyl-19-norpregnane derivatives
03/17/1999CN1042536C Preparation of cephalosporin antibiotic using synisomer of thiazolyl intermediate cis-isomer
03/17/1999CN1042534C Aroyl urea derivatives or preparing method for additive salts of medicinal acid
03/17/1999CN1042533C Substituted 1-(7-chloroquinolin-4-yl) pyrazole-3-carboxamide N-oxide derivatives, method of preparing them and the pharmaceutical compositions
03/17/1999CN1042532C Substituted phenyltrifluoethoxypropionic acid and its use
03/17/1999CN1042531C Method for preparing corbostyril derivatives
03/17/1999CN1042492C Preparing method for apovincamine acid ethyl ester
03/17/1999CA2244330A1 Novel histidine kinase
03/16/1999US5883294 Selective thyroid hormone analogs
03/16/1999US5883270 4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growth
03/16/1999US5883257 N-piperidinyl- and N-tetrahydropyridinyl-2-anthracenecarboxamides: dopamine receptor subtype specific ligands
03/16/1999US5883251 Enzyme inhibitors
03/16/1999US5883246 Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
03/16/1999US5883239 aroA
03/16/1999US5883236 Process for N-desmethylating erythromycins and derivatives thereof
03/16/1999US5883137 Compositions and methods for the control of smoking
03/16/1999US5883136 Inhibiting the growth of cells, wherein the cells are growth-dependent on retinol or 14-hydroxy-retroretinol
03/16/1999US5883133 Cardiovascular disorders
03/16/1999US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis
03/16/1999US5883129 Hydroxylated anthranilic acid derivatives
03/16/1999US5883128 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
03/16/1999US5883127 Vision defects, salts
03/16/1999US5883126 Pharmacological use of certain cystine derivatives
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883122 Neuroprotective agents
03/16/1999US5883120 Antifungal activity of the spongistatins
03/16/1999US5883119 Triterpene derivatives with immunosuppressant activity
03/16/1999US5883118 Anticarcinogenic agents
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883115 Transdermal delivery of the eutomer of a chiral drug
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883111 Heterocyclic compounds and their use as angiotensin antagonists
03/16/1999US5883109 Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
03/16/1999US5883108 Combination therapy for treating glaucoma
03/16/1999US5883103 Oral acyclovir delivery
03/16/1999US5883102 Pharmaceutically active compounds
03/16/1999US5883099 Treatment of athersclerosis, pancreatitis obesity or hyperglycemia
03/16/1999US5883096 Di-n-substituted piperazine derivatives; alzheimer*s disease, cognition activators; synergistic mixtures with acetylcholinesterase inhibitors
03/16/1999US5883095 Formulations and methods to treat and prevent equine protozoal myeloencephalitis
03/16/1999US5883092 Pyrimidine derivatives as endothelin antagonists
03/16/1999US5883090 Endothelin receptor antagonists
03/16/1999US5883089 Bactericides and antibiotics
03/16/1999US5883088 Gallium complexes of 3-hydroxy-4-pyrones provide enhanced gallium bioavailability
03/16/1999US5883087 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
03/16/1999US5883085 Salicylic acid for treatment of skins
03/16/1999US5883084 Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine
03/16/1999US5883083 Dietary supplement for alleviating behavioral problems in canines and reducing seizures in canines and felines
03/16/1999US5883080 Antiparastic auermectin derivatives
03/16/1999US5883079 Method for inhibiting H. pylori infection in mammalian tissue
03/16/1999US5883074 Potentiators of antibacterial agents
03/16/1999US5882944 Methods for G protein coupled receptor activity screening
03/16/1999US5882925 Cdna contained in plasmids, amino acid sequences and cultures
03/16/1999US5882910 Lipid kinase
03/16/1999US5882901 Sialylating specified oligosaccharide with sialyltransferase, fucosylating with fucosyltransferase
03/16/1999US5882897 yitJ
03/16/1999US5882896 M protein
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882876 Amino acid sequences in proteins and markers of cancer cells
03/16/1999US5882860 Hybridization of nucleic acid derived from cell with polynucleotide; genetic engineering; suppressing gene expression
03/16/1999US5882850 Method for reducing calcification of biological tissue used implantable bioprostheses
03/16/1999US5882703 Product containing Mortierella sect. schmuckeri lipids
03/16/1999US5882686 Methods for the prevention and treatment of urogenital disorders
03/16/1999US5882682 Controlled release simvastatin delivery device
03/16/1999US5882681 Stabilized tablet formulation
03/16/1999US5882678 Interdigitation-fusion liposomes containing arachidonic acid metabolites
03/16/1999US5882674 Transdermal therapeutic system comprising active substances representing carbon monoxide sources
03/16/1999US5882671 Using an agonist which acts at negatively coupled camp-linked metabotropic glutamate receptors
03/16/1999US5882663 Topical pain-relieving preparation containing C12 To C18 isoparaffins
03/16/1999US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and
03/16/1999US5882648 Methods of disease inhibition using acid polysaccharides extracted from nutshells
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999US5882639 Topically treating photodermatitis, thermal burn, decubitus ulcer, or herpes zoster
03/16/1999US5882627 Methods and compositions for in-vivo detection of oral cancers precancerous conditions
03/16/1999CA2244232A1 Novel def
03/16/1999CA2236363A1 Novel compound
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA2168962C Novel substituted propane-2-ol derivatives
03/16/1999CA2168248C Antifungal nail solution
03/16/1999CA2167198C Benzylaminoquinuclidines
03/16/1999CA2165012C Estrogen agonists
03/16/1999CA2164689C Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
03/16/1999CA2160140C Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/16/1999CA2152819C New antiparasitic agents related to the milbemycins and avermectins
03/16/1999CA2150709C Pyrazolopyrimidines
03/16/1999CA2109861C 6,7-modified paclitaxels
03/16/1999CA2108963C Compositions and methods for therapy and prevention of cancer, aids and anemia
03/16/1999CA2081891C Quinolizinone type compounds
03/16/1999CA2073226C Pyrazolopyrimidinone antianginal agents
03/16/1999CA2058264C Dihydrobenzofuran carboxamides and process for their preparation
03/16/1999CA1340452C Novel hmg-coa reductase inhibitors
1 ... 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 6547 ... 7860